• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障处ATP结合盒转运蛋白介导的外排的体内生物发光成像

In Vivo Bioluminescent Imaging of ATP-Binding Cassette Transporter-Mediated Efflux at the Blood-Brain Barrier.

作者信息

Bakhsheshian Joshua, Wei Bih-Rong, Hall Matthew D, Simpson R Mark, Gottesman Michael M

机构信息

Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

出版信息

Methods Mol Biol. 2016;1461:227-39. doi: 10.1007/978-1-4939-3813-1_19.

DOI:10.1007/978-1-4939-3813-1_19
PMID:27424909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10758286/
Abstract

We provide a detailed protocol for imaging ATP-binding cassette subfamily G member 2 (ABCG2) function at the blood-brain barrier (BBB) of transgenic mice. D-Luciferin is specifically transported by ABCG2 found on the apical side of endothelial cells at the BBB. The luciferase-luciferin enzymatic reaction produces bioluminescence, which allows a direct measurement of ABCG2 function at the BBB. Therefore bioluminescence imaging (BLI) correlates with ABCG2 function at the BBB and this can be measured by administering luciferin in a mouse model that expresses luciferase in the brain parenchyma. BLI allows for a relatively low-cost alternative for studying transporter function in vivo compared to other strategies such as positron emission tomography. This method for imaging ABCG2 function at the BBB can be used to investigate pharmacokinetic inhibition of the transporter.

摘要

我们提供了一个详细的方案,用于在转基因小鼠的血脑屏障(BBB)处对ATP结合盒亚家族G成员2(ABCG2)的功能进行成像。D-荧光素由血脑屏障处内皮细胞顶端侧发现的ABCG2特异性转运。荧光素酶-荧光素酶促反应产生生物发光,这使得能够直接测量血脑屏障处ABCG2的功能。因此,生物发光成像(BLI)与血脑屏障处ABCG2的功能相关,这可以通过在脑实质中表达荧光素酶的小鼠模型中给予荧光素来测量。与正电子发射断层扫描等其他策略相比,BLI为体内研究转运蛋白功能提供了一种成本相对较低的替代方法。这种在血脑屏障处对ABCG2功能进行成像的方法可用于研究该转运蛋白的药代动力学抑制作用。

相似文献

1
In Vivo Bioluminescent Imaging of ATP-Binding Cassette Transporter-Mediated Efflux at the Blood-Brain Barrier.血脑屏障处ATP结合盒转运蛋白介导的外排的体内生物发光成像
Methods Mol Biol. 2016;1461:227-39. doi: 10.1007/978-1-4939-3813-1_19.
2
Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.血脑屏障转运体 ABCG2 介导的药物外排的生物发光成像。
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20801-6. doi: 10.1073/pnas.1312159110. Epub 2013 Dec 2.
3
ATP-binding cassette transporters modulate both coelenterazine- and D-luciferin-based bioluminescence imaging.ATP 结合盒转运蛋白调节腔肠素和 D-荧光素生物发光成像。
Mol Imaging. 2011 Jun;10(3):215-26.
4
ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.ABCG2/BCRP的表达调节基于D-荧光素的生物发光成像。
Cancer Res. 2007 Oct 1;67(19):9389-97. doi: 10.1158/0008-5472.CAN-07-0944.
5
Identification of NanoLuciferase Substrates Transported by Human ABCB1 and ABCG2 and Their Zebrafish Homologs at the Blood-Brain Barrier.鉴定 ABCB1 和 ABCG2 转运的纳米萤光素酶底物及其在血脑屏障的斑马鱼同源物。
Mol Pharmacol. 2024 Nov 18;106(6):278-286. doi: 10.1124/molpharm.123.000811.
6
Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier.ABCG2外排活性在血-胎盘屏障处的生物发光成像。
Sci Rep. 2016 Feb 8;6:20418. doi: 10.1038/srep20418.
7
ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.ABCG2 和 ABCG4 介导的小鼠血脑屏障对淀粉样β肽 1-40 的外排。
J Alzheimers Dis. 2012;30(1):155-66. doi: 10.3233/JAD-2012-112189.
8
Gemcitabine upregulates ABCG2/BCRP and modulates the intracellular pharmacokinetic profiles of bioluminescence in pancreatic cancer cells.吉西他滨上调ABCG2/BCRP并调节胰腺癌细胞中生物发光的细胞内药代动力学特征。
Anticancer Drugs. 2016 Mar;27(3):183-91. doi: 10.1097/CAD.0000000000000315.
9
PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.使用[(18)F] -吉非替尼进行PET-CT成像,以测量小鼠血脑屏障处Abcb1a/1b(P-糖蛋白)和Abcg2(Bcrp1)介导的药物相互作用。
Nucl Med Biol. 2015 Nov;42(11):833-41. doi: 10.1016/j.nucmedbio.2015.07.004. Epub 2015 Jul 15.
10
[(18)F]FDG is not transported by P-glycoprotein and breast cancer resistance protein at the rodent blood-brain barrier.[18F]氟代脱氧葡萄糖在啮齿动物血脑屏障处不会被P-糖蛋白和乳腺癌耐药蛋白转运。
Nucl Med Biol. 2015 Jul;42(7):585-9. doi: 10.1016/j.nucmedbio.2015.03.004. Epub 2015 Mar 18.

引用本文的文献

1
Progress in characterizing ABC multidrug transporters in zebrafish.斑马鱼 ABC 多药转运蛋白的特性研究进展。
Drug Resist Updat. 2024 Jan;72:101035. doi: 10.1016/j.drup.2023.101035. Epub 2023 Dec 17.
2
Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke.血脑屏障转运体:在缺血性脑卒中治疗开发中的机遇。
Int J Mol Sci. 2022 Feb 8;23(3):1898. doi: 10.3390/ijms23031898.
3
The impact of ATP-binding cassette transporters on metabolic diseases.ATP结合盒转运蛋白对代谢性疾病的影响。

本文引用的文献

1
Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.血脑屏障转运体 ABCG2 介导的药物外排的生物发光成像。
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20801-6. doi: 10.1073/pnas.1312159110. Epub 2013 Dec 2.
2
Overlapping substrate and inhibitor specificity of human and murine ABCG2.人源和鼠源 ABCG2 的底物和抑制剂特异性重叠。
Drug Metab Dispos. 2013 Oct;41(10):1805-12. doi: 10.1124/dmd.113.053140. Epub 2013 Jul 18.
3
Boosting bioluminescence neuroimaging: an optimized protocol for brain studies.
Nutr Metab (Lond). 2020 Aug 3;17:61. doi: 10.1186/s12986-020-00478-4. eCollection 2020.
4
Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications.人类ABCG2抑制剂:从技术背景到近期进展及其临床意义
Front Pharmacol. 2019 Mar 5;10:208. doi: 10.3389/fphar.2019.00208. eCollection 2019.
5
Modulation of Opioid Transport at the Blood-Brain Barrier by Altered ATP-Binding Cassette (ABC) Transporter Expression and Activity.通过改变ATP结合盒(ABC)转运蛋白的表达和活性来调节血脑屏障处的阿片类药物转运
Pharmaceutics. 2018 Oct 18;10(4):192. doi: 10.3390/pharmaceutics10040192.
6
Revisiting the role of ABC transporters in multidrug-resistant cancer.重新审视 ABC 转运蛋白在多药耐药性癌症中的作用。
Nat Rev Cancer. 2018 Jul;18(7):452-464. doi: 10.1038/s41568-018-0005-8.
增强生物发光神经成像:脑研究的优化方案。
PLoS One. 2013;8(2):e55662. doi: 10.1371/journal.pone.0055662. Epub 2013 Feb 6.
4
Novel in vivo imaging analysis of an inner ear drug delivery system in mice: comparison of inner ear drug concentrations over time after transtympanic and systemic injections.新型体内成像分析小鼠内耳药物传递系统:鼓室和全身给药后不同时间内耳药物浓度的比较。
PLoS One. 2012;7(12):e48480. doi: 10.1371/journal.pone.0048480. Epub 2012 Dec 12.
5
The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2).“特异性”P-糖蛋白抑制剂 Tariquidar 也是乳腺癌耐药蛋白(BCRP/ABCG2)的底物和抑制剂。
ACS Chem Neurosci. 2011 Feb 16;2(2):82-9. doi: 10.1021/cn100078a. Epub 2010 Oct 21.
6
Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model.比较 Evans 蓝注射途径:静脉内注射与腹腔内注射,用于测量小鼠脑出血模型中的血脑屏障。
J Neurosci Methods. 2011 Feb 15;195(2):206-10. doi: 10.1016/j.jneumeth.2010.12.013. Epub 2010 Dec 17.
7
Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy.血脑屏障处ABC转运蛋白的调控:中枢神经系统治疗的新靶点
Mol Interv. 2010 Oct;10(5):293-304. doi: 10.1124/mi.10.5.6.
8
Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux.吉非替尼向脑内的分布受到 P-糖蛋白(ABCB1)和乳腺癌耐药蛋白(ABCG2)介导的主动外排的限制。
J Pharmacol Exp Ther. 2010 Jul;334(1):147-55. doi: 10.1124/jpet.110.167601. Epub 2010 Apr 26.
9
Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications.用放射性示踪剂成像P-糖蛋白的功能:药代动力学及体内应用
Clin Pharmacol Ther. 2009 Oct;86(4):368-77. doi: 10.1038/clpt.2009.138. Epub 2009 Jul 22.
10
Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.ABCG2(乳腺癌耐药蛋白)的生理和药理作用:Abcg2基因敲除小鼠的最新研究发现
Adv Drug Deliv Rev. 2009 Jan 31;61(1):14-25. doi: 10.1016/j.addr.2008.08.007. Epub 2008 Dec 7.